Latest filing published 16 Aug 2024 for Biora Therapeutics, INC., €16k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Clarke Neumann discloses dealings in Biora Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 May 2021 to 15 August 2024, the count stands at 15 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 16 August 2024: a share grant of €16k, in Biora Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations